BioPharmSignal logoBioPharmSignal

Biotech News

OraSure to Participate in Upcoming Investor Conference

OraSure Technologies, Inc. (OSUR)OraSure Technologies, Inc.Conference / presentation

BETHLEHEM, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference: Stephens Annual Investment Conference on Wednesday, November 19, with a Q&A session scheduled for 10 a.m.

Related news

XGNExagen2026-07-28 13:00 EST

Exagen Inc. to Participate in Upcoming Investor Conference

BDSXBiodesix2026-08-04 10:00 EST

Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

INBSIntelligent Bio Solutions2026-06-04 12:30 EST

Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18

OSUROraSure Technologies, Inc.2026-08-05 20:05 EST

OraSure Announces Second Quarter 2026 Financial Results

OSUROraSure Technologies, Inc.2026-07-22 20:10 EST

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

LUCDLucid Diagnostics2026-04-09 12:01 EST

Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

BJDXBluejay Diagnostics2026-03-12 10:30 EST

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

BDSXBiodesix2025-12-03 13:22 EST

Biodesix to Present New Data at Two Major Upcoming Scientific Meetings

FLGTFulgent Genetics, Inc.2025-10-20 10:00 EST

Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference

LUCDLucid Diagnostics2026-08-04 12:30 EST

Lucid Diagnostics to Participate in Upcoming Investor Conferences

View all latest news

OraSure Technologies, Inc.

Decentralized Diagnostics OraSure Technologies develops point-of-need and at-home diagnostic tests intended to make testing more accessible, private and convenient. Rapid-Test Portfolio The company's products cover infectious diseases and other conditions across consumer, clinical, public-health and community settings. Subsidiaries...

Recent company news

OSUROraSure Technologies, Inc.2026-08-05 20:05 EST

OraSure Announces Second Quarter 2026 Financial Results

OSUROraSure Technologies, Inc.2026-07-22 20:10 EST

OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th

OSUROraSure Technologies, Inc.2026-07-21 20:30 EST

OraSure Receives Emergency Use Authorization for Second Generation Ebola Test

OSUROraSure Technologies, Inc.2026-06-11 12:00 EST

OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections

OSUROraSure Technologies, Inc.2026-05-06 20:05 EST

OraSure Announces First Quarter 2026 Financial Results

Stock data

Close
4.00 USD
Market cap
275.39M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States